Skip to main content

Telomir Pharmaceuticals, Inc. (TELO)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.42
As of

Kresmion compiles this page from TELO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Telomir Pharmaceuticals, Inc. (TELO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-06.

As of . Source: SEC EDGAR filings for TELO. Method and limitations.

COMPANY DOSSIER

See the full TELO dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for TELO on one page. Preview it with sample data, then open it live with a free account.

Preview the TELO dossier

Active events for TELO

FREE, NO ACCOUNT

Every event on TELO, as it fires

You are seeing 5 of 7 events recorded on TELO since 2026-05-30.

The five above landed across 3 days. The other 2 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, TELO

Going concern statement

TELO's 10-Q filed Nov 6, 2026 states:

These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Report.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on TELO

Cite this data

Kresmion counts the managers it follows that reported a non-option position in TELO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TELO in the last 180 days.

Upstream: SEC EDGAR filings for TELO

Kresmion, "Telomir Pharmaceuticals, Inc. (TELO) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/TELO. Upstream data: SEC EDGAR filings for TELO.

Link to this data (HTML):

<a href="https://kresmion.com/research/TELO">Telomir Pharmaceuticals, Inc. (TELO) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow TELO on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TELO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the TELO dossier
Share

The TELO intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.